Skip to main content
BioPorto A/S (CPH: BIOPOR)
Denmark flag Denmark · Delayed Price · Currency is DKK
1.484
-0.108 (-6.78%)
Dec 20, 2024, 4:59 PM CET

BioPorto Revenue

BioPorto had revenue of 9.69M DKK in the quarter ending September 30, 2024, with 12.50% growth. This brings the company's revenue in the last twelve months to 34.91M, up 5.49% year-over-year. In the year 2023, BioPorto had annual revenue of 30.96M with 6.87% growth.

Revenue (ttm)
34.91M
Revenue Growth
+5.49%
P/S Ratio
16.72
Revenue / Employee
969.61K
Employees
29
Market Cap
637.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.96M1.99M6.87%
Dec 31, 202228.97M4.72M19.44%
Dec 31, 202124.25M1.05M4.53%
Dec 31, 202023.20M-3.42M-12.84%
Dec 31, 201926.62M606.00K2.33%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk A/S 270.58B
Coloplast A/S 27.03B
Genmab A/S 19.84B
Demant A/S 22.84B
Zealand Pharma A/S 76.87M
H. Lundbeck A/S 21.44B
H. Lundbeck A/S 21.44B
ALK-Abelló A/S 5.38B
Revenue Rankings

BioPorto News

More News